Stocksigma LogoStocksigma Logo

Kwality Pharmaceuticals Secures Hungarian EU-GMP Approval for Cephalosporin and Oncology Units

Kwality Pharmaceuticals Ltd. has secured EU-GMP approval from Hungary for its Cephalosporin and Oncology manufacturing facilities, complementing its

Kwality Pharmaceuticals Secures Hungarian EU-GMP Approval for Cephalosporin and Oncology Units

Kwality Pharmaceuticals Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 6:29 pm

Kwality Pharmaceuticals Secures Hungarian EU-GMP Approval for Cephalosporin and Oncology Units Kwality Pharmaceuticals Ltd. has secured EU-GMP approval from Hungary for its Cephalosporin and Oncology manufacturing facilities, complementing its existing EU-GMP certification from Bulgaria. This regulatory milestone significantly broadens the company鈥檚 certified capacity across specialized pharmaceutical segments and strengthens its competitive position in highly regulated, high-value global markets. The approval is expected to drive international business growth by unlocking new licensing opportunities and accelerating foreign product registrations.

Original exchange filing (PDF)

More announcements from Kwality Pharmaceuticals Ltd

All Kwality Pharmaceuticals Ltd announcements